ORAL HEALTH AND INFLAMMATION IN PATIENTS WITH END-STAGE RENAL FAILURE

被引:5
|
作者
Bayraktar, Gulsen [2 ]
Kurtulus, Idil [1 ]
Kazancioglu, Rumeyza [3 ]
Bayramgurler, Isil [2 ]
Cintan, Serdar [1 ]
Bural, Canan [2 ]
Bozfakioglu, Semra [4 ]
Issever, Halim [5 ]
Yildiz, Alaattin [4 ]
机构
[1] Istanbul Univ, Fac Dent, Dept Periodontol, TR-34093 Istanbul, Turkey
[2] Istanbul Univ, Fac Dent, Dept Removable Prosthodont, TR-34093 Istanbul, Turkey
[3] Haseki Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[4] Istanbul Univ, Fac Med, Dept Nephrol, TR-34093 Istanbul, Turkey
[5] Istanbul Univ, Fac Med, Dept Publ Hlth, TR-34093 Istanbul, Turkey
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2009年 / 29卷 / 04期
关键词
Saliva; chronic renal insufficiency; decayed; missing; filled teeth; DMFT index; SALIVARY FLOW-RATE; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; PERIODONTAL-DISEASE; BUFFERING CAPACITY; YOUNG-ADULTS; CHILDREN; MARKERS; PH;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: End-stage renal disease (ESRD) patients have an increased risk of atherosclerotic complications. In both hemodialysis (HD) patients and the general population, it has become evident that inflammation plays an important role in the pathogenesis of atherosclerotic complications. Oral and dental problems in ESRD patients could be an important source of inflammation, thus treatment of these problems is important to protect these patients from potential infections. The decayed, missing, and filled teeth (DMFT) index is an indicator of oral and dental health status. Our aim was to analyze and compare salivary flow rate (SFR), salivary pH (SpH), salivary buffering capacity (SBC), and DMFT index and plaque index (PI) values in PD patients to HD patients and healthy controls (C) and establish the relationship between these parameters and C-reactive protein (CRP). Methods: 76 PD patients, 100 HD patients, and 111 Cs were included in the study. SFR (milliliters/minute) was measured in stimulated whole saliva, SpH was measured using the Merck indicator, and SBC was measured according to the method of Ericsson: 1 mL whole saliva was added to 3 mL 0.005 N HCl and a stream of air was passed through this mixture for 20 minutes. Finally, DMFT index and PI values were calculated. Results: No statistically significant differences were found in age or gender distribution among PD, HD, and C groups. There was also no significant difference in time on dialysis between PD and HD groups. SFR was significantly lower in the PD and HD groups than in the C group (1.30 +/- 0.83 and 0.70 +/- 0.32 vs 1.64 +/- 0.45 mL/min) and lower in the HD than in the PD group (p < 0.001). SpH (8.35 +/- 0.43 and 8.12 +/- 0.74 vs 7.16 +/- 0.76) and SBC (7.39 +/- 0.47 and 6.82 +/- 0.70 vs 5.08 +/- 0.73) were significantly higher in the PD and HD groups than in the C group and higher in the PD than in the HD group (p < 0.05 and p < 0.001 respectively). The numbers of filled teeth were significantly higher in the PD than in the HD and C groups (p < 0.001). DMFT index was significantly higher in the PD than in the HD group (p < 0.001). Finally, PI values were significantly higher in the PD and HD groups than in the C group (p < 0.001) and higher in the HD than in the PD group, although this was not statistically significant. In the present study, we also found higher CRP values in HD than in PD patients and a positive correlation between CRP and PI values in PD patients. Conclusions: PD patients have higher SFR, SpH, and SBC values than HD patients; however, higher DMFT index and higher numbers of filled teeth were observed in PD patients. Compared to healthy controls, patients on dialysis had worse dental and periodontal findings, which might have a role in microinflammation in this group of patients.
引用
收藏
页码:472 / 479
页数:8
相关论文
共 50 条
  • [21] RENAL OSTEODYSTROPHY IN END-STAGE RENAL-FAILURE PATIENTS IN ISRAEL
    BONER, G
    OLAH, AJ
    WEISS, A
    SEELENFREUND, MZ
    ROSENFELD, JB
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (07): : 608 - 613
  • [22] Acidosis in end-stage renal failure
    Leunissen, KML
    BLOOD PURIFICATION, 1995, 13 (06) : 358 - 360
  • [23] Renal bone disease in Slovenian patients with end-stage renal failure
    Legan, M
    Benedik, M
    Kovac, D
    Cör, A
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 1173 - 1176
  • [24] END-STAGE RENAL-FAILURE
    COBURN, JW
    POSTGRADUATE MEDICINE, 1978, 64 (05) : 86 - 87
  • [25] Quality of life in patients treated for end-stage renal failure
    Patte, D
    PRESSE MEDICALE, 1998, 27 (29): : 1499 - 1505
  • [26] PHARMACOKINETICS OF KETOPROFEN IN PATIENTS WITH END-STAGE RENAL-FAILURE
    GRUBB, NG
    RUDY, DW
    HALL, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 222 - 222
  • [27] MORTALITY IN PATIENTS WITH FABRY DISEASE AND END-STAGE RENAL FAILURE
    Karovaikina, Ekaterina
    Moiseev, Sergey
    Bulanov, Nikolay
    Moiseev, Alexey
    Kuchieva, Agunda
    Fomin, Viktor
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 371 - 371
  • [28] Cardiac surgery in end-stage renal failure patients - Reply
    Braden, GL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) : 1106 - 1106
  • [29] IMMUNOGLOBULIN ALLOTYPES IN PATIENTS IN END-STAGE RENAL-FAILURE
    LAUNDY, GJ
    BRADLEY, BA
    JOURNAL OF IMMUNOGENETICS, 1985, 12 (4-5): : 181 - 190
  • [30] PHARMACOLOGY OF VECURONIUM IN PATIENTS WITH END-STAGE RENAL-FAILURE
    MEISTELMAN, C
    LIENHART, A
    LEVEQUE, C
    BITKER, MO
    PIGOT, B
    VIARS, P
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1986, 3 (02) : 153 - 158